GlaxoSmithKline (GSK)

Warning! As of 20 September 2021, the EU lobby register has changed format. Temporarily, the register is no longer providing daily data updates of all lobby data which means that the figures on LobbyFacts cannot currently be kept up-to-date. If, for example, you see a company, trade association, or lobby consultancy with "no figure available" for EU lobby costs, open the data card, and click the link to the EU lobby register where you will find the updated registration including EU lobby costs declaration. Regretably, under the lobby register format, NGOs and think tanks are no longer required to provide a figure for EU lobby costs. We will update LobbyFacts with the new data as soon as possible.

Tweet this page
How to read and use this data card.

Lobbying costs:

WARNING: As this organisation lists one or more EP accredited lobbyists, it is highly improbable that its lobbying costs are lower than €10,000.

WARNING: The lobbying costs declared by this organisation are extraordinarily high and may therefore have been over-declared.

1,000,000€ - 1,249,999€

Financial year: 01/01/2020 - 01/12/2020

Lobbyists declared: 5.25 FTE (9)

WARNING: The number of full time equivalent lobbyists declared by this organisation are extraordinarily high and may therefore have been over-declared.


Lobbyists with EP accreditation: 4


Meetings with European Commission: 11

Lobbying costs over the years:


GlaxoSmithKline (GSK)

Registration on EU Transparency Register

7990322925-77 (First registered: 06 Jan 2009)

Goals / Remit

We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. Our goal is to be one of the world’s most innovative, best performing and trusted healthcare companies. We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our three global businesses, scientific and technical know-how and talented people. Our operations span the value chain from identifying, researching, developing and testing ground-breaking discoveries, to regulatory approval, manufacturing and commercialisation. We have over 94,000 employees globally across 96 countries, with outstanding scientific and technical know-how and deep expertise. In Europe, we employ over 25,000 people, with 14 manufacturing sites and 4 R&D sites in EU countries.


We follow EU initiatives, policies and legislative files related to our Pharmaceuticals, Vaccines and Consumer Healthcare businesses. This includes topics such as R&D and clinical trials, the EU Beating Cancer Plan, health technology assessment, antimicrobial resistance, digital health, pharmaceutical legislation, medical devices, vaccines, trade, industrial strategy, IP, environment.


Head office:
Great West Road, 980
Brentford, Middlesex TW8 9GS
United Kingdom

Tel: 44 20 8047 5000

Belgium office:
37 Square de Meeûs
Brussels 1000,

Tel: 32 27917600